HEADER TRANSFERASE/TRANSFERASE ACTIVATOR 30-JAN-12 4DHY TITLE CRYSTAL STRUCTURE OF HUMAN GLUCOKINASE IN COMPLEX WITH GLUCOSE AND TITLE 2 ACTIVATOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLUCOKINASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 12-465; COMPND 5 SYNONYM: HEXOKINASE TYPE IV, HK IV, HEXOKINASE-4, HK4, HEXOKINASE-D; COMPND 6 EC: 2.7.1.2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: GCK; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS DIABETES MELLITUS, DISEASE MUTATION, GLYCOLYSIS, TRANSFERASE, KEYWDS 2 TRANSFERASE-TRANSFERASE ACTIVATOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.LIU REVDAT 5 13-SEP-23 4DHY 1 HETSYN REVDAT 4 29-JUL-20 4DHY 1 COMPND REMARK SEQADV HETNAM REVDAT 4 2 1 LINK SITE REVDAT 3 09-MAY-12 4DHY 1 JRNL REVDAT 2 11-APR-12 4DHY 1 JRNL REVDAT 1 08-FEB-12 4DHY 0 JRNL AUTH S.LIU,M.J.AMMIRATI,X.SONG,J.D.KNAFELS,J.ZHANG,S.E.GREASLEY, JRNL AUTH 2 J.A.PFEFFERKORN,X.QIU JRNL TITL INSIGHTS INTO MECHANISM OF GLUCOKINASE ACTIVATION: JRNL TITL 2 OBSERVATION OF MULTIPLE DISTINCT PROTEIN CONFORMATIONS. JRNL REF J.BIOL.CHEM. V. 287 13598 2012 JRNL REFN ISSN 0021-9258 JRNL PMID 22298776 JRNL DOI 10.1074/JBC.M111.274126 REMARK 2 REMARK 2 RESOLUTION. 2.38 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.2 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.38 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 52.90 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.2 REMARK 3 NUMBER OF REFLECTIONS : 18915 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.186 REMARK 3 R VALUE (WORKING SET) : 0.183 REMARK 3 FREE R VALUE : 0.244 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.970 REMARK 3 FREE R VALUE TEST SET COUNT : 941 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.38 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.51 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.18 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2541 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.1998 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2410 REMARK 3 BIN R VALUE (WORKING SET) : 0.1976 REMARK 3 BIN FREE R VALUE : 0.2410 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.16 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 131 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3506 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 45 REMARK 3 SOLVENT ATOMS : 181 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 35.87 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.19 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.83380 REMARK 3 B22 (A**2) : -4.96120 REMARK 3 B33 (A**2) : 2.12740 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.288 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.435 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.929 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.887 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 3651 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 4918 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1346 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 102 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 539 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 3651 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : 0 ; 5.000 ; SEMIHARMONIC REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 461 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 4391 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.18 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.02 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 19.30 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: A 4 A 458 REMARK 3 ORIGIN FOR THE GROUP (A): -27.5812 -0.8077 9.5699 REMARK 3 T TENSOR REMARK 3 T11: -0.0570 T22: -0.0552 REMARK 3 T33: -0.0339 T12: -0.0181 REMARK 3 T13: 0.0166 T23: 0.0065 REMARK 3 L TENSOR REMARK 3 L11: 0.4646 L22: 0.6121 REMARK 3 L33: 0.5009 L12: -0.0177 REMARK 3 L13: 0.0090 L23: 0.0428 REMARK 3 S TENSOR REMARK 3 S11: -0.0223 S12: -0.0259 S13: 0.0338 REMARK 3 S21: -0.0011 S22: 0.0436 S23: -0.0164 REMARK 3 S31: 0.0105 S32: 0.0065 S33: -0.0214 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4DHY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 31-JAN-12. REMARK 100 THE DEPOSITION ID IS D_1000070351. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-OCT-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 944 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18951 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.380 REMARK 200 RESOLUTION RANGE LOW (A) : 52.900 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.8 REMARK 200 DATA REDUNDANCY : 5.300 REMARK 200 R MERGE (I) : 0.10900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.38 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.51 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.5 REMARK 200 DATA REDUNDANCY IN SHELL : 3.80 REMARK 200 R MERGE FOR SHELL (I) : 0.40300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: 3F9M REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.12 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.24 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 7.5, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 33.50500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 43.08000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 41.10000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 43.08000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 33.50500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 41.10000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -3 REMARK 465 HIS A -2 REMARK 465 HIS A -1 REMARK 465 HIS A 0 REMARK 465 HIS A 1 REMARK 465 HIS A 2 REMARK 465 HIS A 3 REMARK 465 GLU A 93 REMARK 465 GLY A 94 REMARK 465 GLU A 95 REMARK 465 GLU A 96 REMARK 465 GLY A 97 REMARK 465 GLN A 98 REMARK 465 TRP A 99 REMARK 465 LYS A 459 REMARK 465 ALA A 460 REMARK 465 CYS A 461 REMARK 465 MET A 462 REMARK 465 LEU A 463 REMARK 465 GLY A 464 REMARK 465 GLN A 465 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 67 CB CG CD OE1 OE2 REMARK 470 LYS A 140 CD CE NZ REMARK 470 LYS A 142 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 5 110.28 62.78 REMARK 500 MET A 57 55.83 39.80 REMARK 500 GLU A 67 -149.46 140.61 REMARK 500 ASN A 83 -172.09 81.28 REMARK 500 GLN A 138 74.57 45.49 REMARK 500 MET A 139 24.42 -160.60 REMARK 500 LYS A 172 15.10 -141.05 REMARK 500 HIS A 218 -7.83 -57.35 REMARK 500 ARG A 345 2.97 82.05 REMARK 500 ARG A 358 75.66 -112.59 REMARK 500 THR A 431 59.56 -116.12 REMARK 500 CYS A 457 36.53 -67.73 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA A 503 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 MET A 238 O REMARK 620 2 VAL A 241 O 91.8 REMARK 620 3 VAL A 244 O 142.1 79.2 REMARK 620 4 GLY A 246 O 79.3 162.6 98.7 REMARK 620 N 1 2 3 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3S41 RELATED DB: PDB REMARK 900 RELATED ID: 3VEV RELATED DB: PDB REMARK 900 RELATED ID: 3VE6 RELATED DB: PDB REMARK 900 RELATED ID: 3VF6 RELATED DB: PDB REMARK 900 RELATED ID: 4DCH RELATED DB: PDB DBREF 4DHY A 12 465 UNP P35557 HXK4_HUMAN 12 465 SEQADV 4DHY MET A -3 UNP P35557 EXPRESSION TAG SEQADV 4DHY HIS A -2 UNP P35557 EXPRESSION TAG SEQADV 4DHY HIS A -1 UNP P35557 EXPRESSION TAG SEQADV 4DHY HIS A 0 UNP P35557 EXPRESSION TAG SEQADV 4DHY HIS A 1 UNP P35557 EXPRESSION TAG SEQADV 4DHY HIS A 2 UNP P35557 EXPRESSION TAG SEQADV 4DHY HIS A 3 UNP P35557 EXPRESSION TAG SEQADV 4DHY GLU A 4 UNP P35557 EXPRESSION TAG SEQADV 4DHY ASN A 5 UNP P35557 EXPRESSION TAG SEQADV 4DHY LEU A 6 UNP P35557 EXPRESSION TAG SEQADV 4DHY TYR A 7 UNP P35557 EXPRESSION TAG SEQADV 4DHY PHE A 8 UNP P35557 EXPRESSION TAG SEQADV 4DHY GLN A 9 UNP P35557 EXPRESSION TAG SEQADV 4DHY GLY A 10 UNP P35557 EXPRESSION TAG SEQADV 4DHY MET A 11 UNP P35557 EXPRESSION TAG SEQRES 1 A 469 MET HIS HIS HIS HIS HIS HIS GLU ASN LEU TYR PHE GLN SEQRES 2 A 469 GLY MET LYS LYS GLU LYS VAL GLU GLN ILE LEU ALA GLU SEQRES 3 A 469 PHE GLN LEU GLN GLU GLU ASP LEU LYS LYS VAL MET ARG SEQRES 4 A 469 ARG MET GLN LYS GLU MET ASP ARG GLY LEU ARG LEU GLU SEQRES 5 A 469 THR HIS GLU GLU ALA SER VAL LYS MET LEU PRO THR TYR SEQRES 6 A 469 VAL ARG SER THR PRO GLU GLY SER GLU VAL GLY ASP PHE SEQRES 7 A 469 LEU SER LEU ASP LEU GLY GLY THR ASN PHE ARG VAL MET SEQRES 8 A 469 LEU VAL LYS VAL GLY GLU GLY GLU GLU GLY GLN TRP SER SEQRES 9 A 469 VAL LYS THR LYS HIS GLN MET TYR SER ILE PRO GLU ASP SEQRES 10 A 469 ALA MET THR GLY THR ALA GLU MET LEU PHE ASP TYR ILE SEQRES 11 A 469 SER GLU CYS ILE SER ASP PHE LEU ASP LYS HIS GLN MET SEQRES 12 A 469 LYS HIS LYS LYS LEU PRO LEU GLY PHE THR PHE SER PHE SEQRES 13 A 469 PRO VAL ARG HIS GLU ASP ILE ASP LYS GLY ILE LEU LEU SEQRES 14 A 469 ASN TRP THR LYS GLY PHE LYS ALA SER GLY ALA GLU GLY SEQRES 15 A 469 ASN ASN VAL VAL GLY LEU LEU ARG ASP ALA ILE LYS ARG SEQRES 16 A 469 ARG GLY ASP PHE GLU MET ASP VAL VAL ALA MET VAL ASN SEQRES 17 A 469 ASP THR VAL ALA THR MET ILE SER CYS TYR TYR GLU ASP SEQRES 18 A 469 HIS GLN CYS GLU VAL GLY MET ILE VAL GLY THR GLY CYS SEQRES 19 A 469 ASN ALA CYS TYR MET GLU GLU MET GLN ASN VAL GLU LEU SEQRES 20 A 469 VAL GLU GLY ASP GLU GLY ARG MET CYS VAL ASN THR GLU SEQRES 21 A 469 TRP GLY ALA PHE GLY ASP SER GLY GLU LEU ASP GLU PHE SEQRES 22 A 469 LEU LEU GLU TYR ASP ARG LEU VAL ASP GLU SER SER ALA SEQRES 23 A 469 ASN PRO GLY GLN GLN LEU TYR GLU LYS LEU ILE GLY GLY SEQRES 24 A 469 LYS TYR MET GLY GLU LEU VAL ARG LEU VAL LEU LEU ARG SEQRES 25 A 469 LEU VAL ASP GLU ASN LEU LEU PHE HIS GLY GLU ALA SER SEQRES 26 A 469 GLU GLN LEU ARG THR ARG GLY ALA PHE GLU THR ARG PHE SEQRES 27 A 469 VAL SER GLN VAL GLU SER ASP THR GLY ASP ARG LYS GLN SEQRES 28 A 469 ILE TYR ASN ILE LEU SER THR LEU GLY LEU ARG PRO SER SEQRES 29 A 469 THR THR ASP CYS ASP ILE VAL ARG ARG ALA CYS GLU SER SEQRES 30 A 469 VAL SER THR ARG ALA ALA HIS MET CYS SER ALA GLY LEU SEQRES 31 A 469 ALA GLY VAL ILE ASN ARG MET ARG GLU SER ARG SER GLU SEQRES 32 A 469 ASP VAL MET ARG ILE THR VAL GLY VAL ASP GLY SER VAL SEQRES 33 A 469 TYR LYS LEU HIS PRO SER PHE LYS GLU ARG PHE HIS ALA SEQRES 34 A 469 SER VAL ARG ARG LEU THR PRO SER CYS GLU ILE THR PHE SEQRES 35 A 469 ILE GLU SER GLU GLU GLY SER GLY ARG GLY ALA ALA LEU SEQRES 36 A 469 VAL SER ALA VAL ALA CYS LYS LYS ALA CYS MET LEU GLY SEQRES 37 A 469 GLN HET GLC A 501 12 HET S41 A 502 32 HET NA A 503 1 HETNAM GLC ALPHA-D-GLUCOPYRANOSE HETNAM S41 N,N-DIMETHYL-5-({2-METHYL-6-[(5-METHYLPYRAZIN-2-YL) HETNAM 2 S41 CARBAMOYL]-1-BENZOFURAN-4-YL}OXY)PYRIMIDINE-2- HETNAM 3 S41 CARBOXAMIDE HETNAM NA SODIUM ION HETSYN GLC ALPHA-D-GLUCOSE; D-GLUCOSE; GLUCOSE FORMUL 2 GLC C6 H12 O6 FORMUL 3 S41 C22 H20 N6 O4 FORMUL 4 NA NA 1+ FORMUL 5 HOH *181(H2 O) HELIX 1 1 ASN A 5 ALA A 21 1 17 HELIX 2 2 GLU A 22 GLN A 24 5 3 HELIX 3 3 GLN A 26 ARG A 46 1 21 HELIX 4 4 PRO A 111 THR A 116 1 6 HELIX 5 5 THR A 118 HIS A 137 1 20 HELIX 6 6 ASN A 180 GLY A 193 1 14 HELIX 7 7 ASN A 204 ASP A 217 1 14 HELIX 8 8 GLU A 256 PHE A 260 5 5 HELIX 9 9 LEU A 266 LEU A 270 5 5 HELIX 10 10 LEU A 271 SER A 280 1 10 HELIX 11 11 TYR A 289 ILE A 293 5 5 HELIX 12 12 GLY A 294 GLU A 312 1 19 HELIX 13 13 LEU A 315 GLU A 319 5 5 HELIX 14 14 GLU A 331 ASP A 341 1 11 HELIX 15 15 ARG A 345 LEU A 355 1 11 HELIX 16 16 SER A 360 ARG A 397 1 38 HELIX 17 17 GLY A 410 HIS A 416 1 7 HELIX 18 18 SER A 418 THR A 431 1 14 HELIX 19 19 GLU A 443 CYS A 457 1 15 SHEET 1 A 6 LEU A 58 ARG A 63 0 SHEET 2 A 6 ARG A 250 ASN A 254 -1 O ASN A 254 N LEU A 58 SHEET 3 A 6 CYS A 230 GLU A 237 -1 N GLU A 236 O MET A 251 SHEET 4 A 6 CYS A 220 VAL A 226 -1 N ILE A 225 O ASN A 231 SHEET 5 A 6 MET A 402 ASP A 409 1 O GLY A 407 N VAL A 222 SHEET 6 A 6 CYS A 434 GLU A 440 1 O GLU A 435 N MET A 402 SHEET 1 B 5 LYS A 102 TYR A 108 0 SHEET 2 B 5 PHE A 84 VAL A 91 -1 N PHE A 84 O TYR A 108 SHEET 3 B 5 GLY A 72 LEU A 79 -1 N GLY A 72 O VAL A 91 SHEET 4 B 5 LEU A 144 PHE A 150 1 O THR A 149 N LEU A 77 SHEET 5 B 5 MET A 197 VAL A 203 1 O ASP A 198 N LEU A 146 SHEET 1 C 2 VAL A 154 ASP A 158 0 SHEET 2 C 2 LYS A 161 LEU A 164 -1 O LYS A 161 N GLU A 157 LINK O MET A 238 NA NA A 503 1555 1555 2.32 LINK O VAL A 241 NA NA A 503 1555 1555 2.27 LINK O VAL A 244 NA NA A 503 1555 1555 2.34 LINK O GLY A 246 NA NA A 503 1555 1555 2.35 CRYST1 67.010 82.200 86.160 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014923 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012165 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011606 0.00000